Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Review
New PDL1 inhibitors for non-small cell lung cancer: focus on pembrolizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 16,303 | Dovepress* | 13,264+ | 1,350 | 14,614 | |
| PubMed Central* | 3,039 | 806 | 3,845 | ||
| Totals | 16,303 | 2,156 | 18,459 | ||
| *Since 16 July 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 18 | 0 | 0 | 0 | 9 | 9 |
View citations on PubMed Central and Google Scholar